Genomic approaches to identify and investigate genes associated with atrial fibrillation and heart failure susceptibility
Abstract Atrial fibrillation (AF) and heart failure (HF) contribute to about 45% of all cardiovascular disease (CVD) deaths in the USA and around the globe. Due to the complex nature, progression, inherent genetic makeup, and heterogeneity of CVDs, personalized treatments are believed...
Main Authors: | Patel, Kush K., Venkatesan, Cynthia, Abdelhalim, Habiba, Zeeshan, Saman, Arima, Yuichiro, Linna-Kuosmanen, Suvi, Ahmed, Zeeshan |
---|---|
Other Authors: | Massachusetts Institute of Technology. Computer Science and Artificial Intelligence Laboratory |
Format: | Article |
Language: | English |
Published: |
BioMed Central
2023
|
Online Access: | https://hdl.handle.net/1721.1/150862 |
Similar Items
-
A mathematical model for atrial fibrillation
by: Berger, Ronald David
Published: (2006) -
Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis
by: Chan, Kevin E., et al.
Published: (2016) -
Warfarin doses in the initiation phase among patients with heart valve replacement and atrial fibrillation in
Hospital Pulau Pinang
by: Jia, Teoh Chee
Published: (2011) -
Warfarin doses in the initiation phase among patients
with heart valve replacement and atrial fibrillation in
Hospital Pulau Pinang
by: Jia, Teoh Chee
Published: (2011) -
Hybrid decision support to monitor atrial fibrillation for stroke prevention
by: Lei, Ningrong, et al.
Published: (2021)